Loading
Latest filing published 25 Jun 2026 for Cipher Pharmaceuticals Inc., €19k. Read the official filing
No signal scores available.
This profile gathers the share dealings of Ryan Mailling in Cipher Pharmaceuticals Inc. We count 2 filings; the first trade dates from 30 September 2024 and the latest from 23 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 25 June 2026: an option exercise of €19k, in Cipher Pharmaceuticals Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations